Drug Markets/Tofacitinib

Tofacitinib

3 NDCs across 1 manufacturer|0 Generic,3 Brand

Tofacitinib is used to treat rheumatoid arthritis, per the National Library of Medicine's MED-RT classification.

▸ More about this market

Tofacitinib is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $73.77 to $207.90 per EA — the most expensive product costs about 2.8× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

3

0G / 3B

Manufacturers

1

competing in market

Price Spread

$73.77 – $207.90

per EA

7d Activity

2↑1 flat

avg +0.1% WoW · of 3 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing TOFACITINIB

Drug Portfolio

3 NDCs total, 3 shown

Drug ↕Price 7d Change ↕
XELJANZ XR 11 MG TABLET
$207.8962
per EA
+0.01%
XELJANZ 10 MG TABLET
$103.9384
per EA
—
XELJANZ 5 MG TABLET
$73.7716
per EA
+0.14%

Frequently Asked Questions

What is Tofacitinib used to treat?

Tofacitinib is used to treat rheumatoid arthritis, per the National Library of Medicine's MED-RT classification.

How many Tofacitinib products are on the market?

The Tofacitinib drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.

What is the price range for Tofacitinib?

NADAC reference prices for Tofacitinib range from $73.7716 to $207.8962 per EA — the most expensive product costs about 2.8× the cheapest.

Which manufacturers make Tofacitinib?

1 manufacturer lists Tofacitinib in NADAC. Ranked by number of NDCs, the largest are Pfizer Inc. (3).

How has the price of Tofacitinib changed recently?

Over the past 7 days, 2 Tofacitinib NDCs rose and 0 fell, with a market-wide average change of +0.1%.